AB 775

This bill prevents every health insurance policy and every self-insured governmental health plan that covers medically necessary epinephrine delivery systems from imposing cost sharing in an amount that exceeds $60 for two doses of the epinephrine delivery system, regardless of the type of epinephrine delivery system. The bill defines “epinephrine delivery system” to mean a device that is approved by the federal Food and Drug Administration, that contains a premeasured dose of epinephrine, and that is used to administer epinephrine into the human body to prevent or treat a life-threatening allergic reaction. Health insurance policies are referred to in the bill as disability insurance policies.